Gorlin Syndrome, a rare genetic disorder, leads to multiple basal cell carcinomas and other complications, requiring innovative treatments. Hightower Clinical is conducting phase 3 clinical trials in Oklahoma City to test a potential drug for Gorlin Syndrome. Participation is voluntary, with no cost involved. Participants will be assigned to either a Control group receiving a placebo or an Experimental group using the investigational drug. These trials are double-blind, ensuring unbiased results. If you’re 18 or older and living with Gorlin Syndrome, you may qualify. Discover how you can contribute to groundbreaking research by joining today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.